Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism SANS modulators(USH1 protein network component sans modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Usher Syndromes | Preclinical | FR | 02 Feb 2022 |